Related Experiment Video
Updated: Jul 4, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Randomized controlled trial of nebulized adrenaline in acute bronchiolitis
Suriyanarayanapillai Hariprakash1, John Alexander, Will Carroll
1Department of Paediatrics, North Staffordshire Hospital NHS Trust, Stoke-on-Trent, United Kingdom.
Insights
Nebulized epinephrine did not significantly reduce hospital admissions for infants with acute bronchiolitis. This emergency room treatment showed no significant advantage over nebulized saline in improving respiratory status.
Area of Science:
- Pediatrics
- Emergency Medicine
- Pulmonology
Background:
- Acute bronchiolitis is a common viral respiratory infection in infants.
- Epinephrine (adrenaline) has been explored for its potential to improve respiratory symptoms.
Purpose of the Study:
- To evaluate if nebulized epinephrine reduces hospital admissions in infants with acute bronchiolitis.
- To assess the impact of nebulized epinephrine on clinical respiratory parameters.
Main Methods:
- A randomized, double-blind, placebo-controlled study involving 75 infants (1 month to 1 year) with acute bronchiolitis.
- Infants received either nebulized epinephrine or normal saline, with clinical assessments every 15 minutes for 2 hours.
- Primary endpoint was hospital admission; secondary endpoints included respiratory rate, oxygen saturation, heart rate, and respiratory distress score.
Main Results:
- Hospital admission rates were 50% for epinephrine and 38% for saline, a difference that was not statistically significant.
- No significant differences were observed in respiratory rate, oxygen saturation, heart rate, or composite respiratory distress scores between groups at any time point.
- Nebulized epinephrine did not demonstrate a significant clinical advantage over nebulized saline.
Conclusions:
- Nebulized epinephrine is not superior to nebulized saline for emergency room management of acute bronchiolitis in infants.
- Further research may be needed to identify effective treatments for reducing hospital admissions in these patients.
Abstract:
Use of both l-epinephrine and racemic epinephrine (adrenaline) has improved clinical symptoms and composite respiratory scores in acute bronchiolitis. The objective of this randomized double-blind placebo-controlled study was to assess whether there was sufficient improvement in clinical state to reduce hospital admissions. Seventy-five infants aged 1 month to 1 year with a clinical diagnosis of acute bronchiolitis were treated with either 2 ml of 1:1000 nebulized adrenaline or 2 ml of nebulized normal saline administered after baseline assessment and 30 min later. Clinical respiratory parameters were recorded at 15-min intervals for a period of 2 h following the baseline assessment. Admission to hospital was the primary end-point and changes in respiratory parameters were secondary end-points. Fifty percent (19/38) of infants treated with adrenaline were discharged home compared with 38 percent (14/37) of those treated with saline. This 12 percent reduction in rate of admission is not statistically significant (95% CI of difference: -10% to 35%). There was no difference between treated and placebo groups in respiratory rate, oxygen saturation, heart rate or a composite respiratory distress score at 30, 60 or 120 min post-treatment. In this study, nebulized epinephrine did not confer a significant advantage over nebulized saline in the emergency room treatment of acute bronchiolitis.
Related Concept Videos
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
COPD: Management Using Bronchodilators and Corticosteroids
Acute Respiratory Failure-IV
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

